Area of research
Epidemiology · Reproductive Medicine
Research interest
Research interests include Cervical Cancer and HPV Research, Ovarian cancer diagnosis and treatment, Gestational Trophoblastic Disease Studies, and Endometrial and Cervical Cancer Treatments.
Diagnosis and management of gestational trophoblastic disease: 2025 update
Diagnosis and management of gestational trophoblastic disease: 2025 update.
A Mobile App for Promoting Breastfeeding-Friendly Communities in Hong Kong: Design and Development Study.
Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. <i>Cancers</i> 2019, <i>11</i>, 813.
bfGPS®: A mobile app for promoting breastfeeding-friendly communities. A design and development study (Preprint)
A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
Evaluation of an Isothermal Amplification HPV Assay on Self-Collected Vaginal Samples as Compared to Clinician-Collected Cervical Samples.
The Value of Four-Quadrant Cervical Biopsy in Women with Different Colposcopic Impressions.
Data from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Supplementary Data from ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer
Supplemental Legends from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Figure S1 from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Data from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Figure S2 from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Figure S3 from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Supplemental Legends from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Figure S3 from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Figure S2 from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Supplementary Data from ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer
Data from ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer
Data from ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer
Figure S1 from CD71<sup>+</sup> Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Association between High Diffusion-Weighted Imaging-Derived Functional Tumor Burden of Peritoneal Carcinomatosis and Overall Survival in Patients with Advanced Ovarian Carcinoma.
Diagnosis and management of gestational trophoblastic disease: 2021 update
An Interactive Web-Based Sexual Health Literacy Program for Safe Sex Practice for Female Chinese University Students: Multicenter Randomized Controlled Trial.
Tamoxifen use in recurrent ovarian cancer in a Chinese population: A 15 -year clinical experience in a tertiary referral center.
PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via α5β1 integrin and JNK/IL-8 signaling.
Primary HPV testing with cytology versus cytology alone in cervical screening-A prospective randomized controlled trial with two rounds of screening in a Chinese population.
Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.
Predictive biomarkers and tumor microenvironment in female genital melanomas: a multi-institutional study of 55 cases.